Trichloroethylene (TCE) is a hazardous, chlorinated solvent that was once widely used as a medical anaesthetic, an industrial degreaser and an ingredient in many consumer products. Due to mounting health concerns including liver toxicity, neurological effects and cancer, US federal and state agencies began to implement controls on its use in the 1980s. While uses such as anaesthesia, aerosol degreasing and dry cleaning have been banned, TCE is still legally permitted for industrial metal degreasing under controlled conditions, as a chemical intermediate, and in some specialised industrial cleaning applications – a continued use that carries unknown implications for public health.
A recent study published in Neurology in October 2025 by Krzyzanowski and colleagues strongly suggests that both occupational exposure to TCE and exposure via contaminated drinking water may significantly increase the risk of developing Parkinson’s disease (PD). The nationwide, population-based study, which compared 221,789 incident PD cases among US Medicare beneficiaries aged 67 and older with more than 1.13 million matched controls, found a clear dose-dependent association between ambient (outdoor) TCE concentrations and PD risk. Beneficiaries exposed to the highest levels of TCE (the top decile, 0.14–8.66μg/m3) had a 10% greater risk of developing PD compared to those exposed to the lowest levels.
Go deeper with GlobalData
Access deeper industry intelligence
Experience unmatched clarity with a single platform that combines unique data, AI, and human expertise.
The hypothesised mechanism for this damage is that TCE selectively harms dopaminergic neurons in the brain through several processes: disrupting cellular energy production via mitochondrial dysfunction, causing damage via oxidative stress and potentially activating the LRRK2 protein, which is a known genetic risk factor for Parkinson’s.
GlobalData epidemiologists forecast that in the US, there will be 1.03 million diagnosed prevalent cases of PD in 2025, which is expected to increase to 1.2 million by 2033. GlobalData epidemiologists anticipate that if regulations were to be put in place to ban all TCE use in the US, diagnosed prevalent cases of PD would decline.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData
